We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Panacea Acquisition Corporation II | NASDAQ:PANA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.24 | 10.22 | 16.40 | 0 | 01:00:00 |
FORM 4
☒
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * EcoR1 Panacea Holdings II, LLC | 2. Issuer Name and Ticker or Trading Symbol Panacea Acquisition Corp. II [ PANA ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person | |
Rule 10b5-1(c) Transaction Indication
☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Class A ordinary shares | 4/28/2023 | D(1) | 545000 | D | (1) | 0 | D (2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Remarks: Oleg Nodelman, the manager of each of the General Partners, serves on the board of directors of the Company. For the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each of the Reporting Persons (other than Mr. Nodelman) may be deemed a director by deputization with respect to the Company on the basis of Mr. Nodelman's service on the Company's board of directors. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
EcoR1 Panacea Holdings II, LLC C/O PANACEA ACQUISITION CORP. II 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO, CA 94103 | X | X | |||
EcoR1 Capital Fund, L.P. C/O PANACEA ACQUISITION CORP. II 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO, CA 94103 | X | X | |||
EcoR1 Capital Fund Qualified, L.P. C/O PANACEA ACQUISITION CORP. II 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO, CA 94103 | X | X | |||
EcoR1 Venture Opportunity Fund, LP C/O PANACEA ACQUISITION CORP. II 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO, CA 94103 | X | X | |||
EcoR1 Capital, LLC C/O PANACEA ACQUISITION CORP. II 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO, CA 94103 | X | X | |||
Biotech Opportunity GP, LLC C/O PANACEA ACQUISITION CORP. II 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO, CA 94103 | X | X | |||
NODELMAN OLEG C/O PANACEA ACQUISITION CORP. II 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO, CA 94103 | X | X |
Signatures | ||
EcoR1 Panacea Holdings II, LLC, By: /s/ Oleg Nodelman, Chief Executive Officer | 5/2/2023 | |
**Signature of Reporting Person | Date | |
EcoR1 Capital Fund, L.P., By: /s/ Oleg Nodelman, Manager of EcoR1 Capital, LLC, its general partner | 5/2/2023 | |
**Signature of Reporting Person | Date | |
EcoR1 Capital Fund Qualified, L.P., By: /s/ Oleg Nodelman, Manager of EcoR1 Capital, LLC, its general partner | 5/2/2023 | |
**Signature of Reporting Person | Date | |
EcoR1 Venture Opportunity Fund, L.P., By: /s/ Oleg Nodelman, Manager of Biotech Opportunity GP, LLC, its general partner | 5/2/2023 | |
**Signature of Reporting Person | Date | |
EcoR1 Capital, LLC, By: /s/ Oleg Nodelman, Manager | 5/2/2023 | |
**Signature of Reporting Person | Date | |
Biotech Opportunity GP, LLC, By: /s/ Oleg Nodelman, Manager | 5/2/2023 | |
**Signature of Reporting Person | Date | |
/s/ Oleg Nodelman | 5/2/2023 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Panacea Acquisition Corp... Chart |
1 Month Panacea Acquisition Corp... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions